Vertex Pharmaceuticals's total assets for Q4 2025 were $26.14B, an increase of 5.15% from the previous quarter. VRTX total liabilities were $7.48B for the fiscal quarter, a -0.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.